Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis

Leukemia

Volumn 12, Issue 11, 1998, Pages 1718-1723

  Cuneo, A ^a   Bigoni, R ^a   Emmanuel, B ^b   Smit, E ^c   Rigolin, G M ^a   Roberti, M G ^a   Bardi, A ^a   Piva, N ^a   Scapoli, G ^a   Castoldi, G ^a   Van Den Berghe, H ^b   Hagemeijer, A ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CML; FISH; t(9; 22) detection

Indexed keywords

BCR ABL PROTEIN; INTERFERON;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; BONE MARROW; CHROMOSOME ANALYSIS; CHROMOSOME BANDING PATTERN; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTERPHASE; MALE; METAPHASE CHROMOSOME; ONCOGENE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0011689252     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401163     Document Type: Article

References (25)

1. Goldman JM. Options for the management of chronic myeloid leukemia. Leuk Lymphoma 1990; 3: 159-164.
2. Kantarjian MH, Deisseroth A, Kurzrock R Estrov Z, Talpaz M. Chronic myelogenous leukemia: a concise update. Blood 1993; 82: 691-703.
3. The Italian Cooperative Study Group on Myeloid Leukemia. Interferon alfa-2a as compared with conventional chemotherapy for treatment of Chronic Myeloid Leukemia. New Engl J Med 1994; 330: 820-826.
4. Le Beau MM. Fluorescence in situ hybridization in cancer diagnosis. In De Vita VT, Hellman S, Rosenberg SA (eds). Important Advances in Oncology. JB Lippincott Co: Philadelphia, 1993: pp 29-45.
5. Amiel A, Yarkoni S, Slavin S, Or R, Lorberboum-Galski H, Fejgin M, Nagler A. Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization. Cancer Genet Cytogenet 1994; 76: 59-64.
6. Cox-Froncillo MC, Cantonetti M, Masi M, Lentini R, Giudiceandrea P, Maffei L, Tribalto M, Amadori S, Papa G. Cytogenetic analysis is non informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-α (IFN-α) therapy. Cancer Genet Cytogenet 1995; 84: 15-18.
7. Tkachuk DC, Westbrook CA, Andreeff M, Donlon TA, Cleary ML, Suryanarayan K, Homge M, Redner A, Gray J, Pinkel D. Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization. Science 1990; 250: 559-562.
8. Seong DC, Song MY, Henske EP, Zimmerman SO, Champlin RE, Deisseroth AB, Siciliano MJ. Analysis of interphase cells for the Philadelphia translocation using painting probe made by inter-Alupolymerase chain reaction from a radiation hybrid. Blood 1994; 83: 2268-2273.
9. Bentz M, Cabot G, Moos M, Speicher MR, Ganser A, Lichter P, Dohner H. Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood 1994; 83: 1922-1928.
10. Sinclair PB, Green AR, Grace C, Nacheva EP. Improved sensitivity of BCR-ABL detection: a triple-probe three-color fluorescence in situ hybridization system. Blood 1994; 90: 1395-1402.
11. Dewald GW, Schad CR, Christensen ER, Tiede AL, Zinsmeister AR, Spurbeck JL, Thibodeau SN, Jalal SM. The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL. Cancer Genet Cytogenet 1993; 71: 7-14.
12. Cox-Froncillo MC, Maffei L, Cantonetti M, Del Poeta G, Lentini R, Bruno A, Masi M, Tribalto M, Amadori S. FISH analysis for CML monitoring. Ann Hematol 1996; 73: 113-119.
13. Sandber AA. The Chromosomes in Human Cancer and Leukemia, 2nd edn. Elsevier: North Holland, New York, 1990, pp 1-55.
14. Hochhaus A, Cross NCP, Goldman J. Monitoring of residual disease in chronic myelogenous leukemia: methodological approaches and clinical aspects. Comments. Leukemia 1996; 10: 904-905.
15. Ozer H, George SL, Schiffer CA, Rao K, Rao PN, Testa JR, LeBeau M, Tantravahi R, Bloomfield CD. Prolonged subcutaneous administration of recombinant α2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B Study 8583. Blood 1993; 82: 2975-2984.
16. Allan NC, Richards SM, Shepard PCA. UK Medical Research Council randomised, multicentre trial of interferon-α in chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. Lancet 1995; 345: 1392-1399.
17. Guilhot F, Chastang C, Michallet M, Guerci A, Harousseau F, Bouabdallah R, Guyotat D, Cheron N, Nicolini F, Abgrall FF, Tanzwer J. Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. New Engl J Med 1997; 4: 223-229.
18. Mecucci C. FISH (fluorescent in situ hybridization): the second youth of cytogenetics. Haematologica 1995; 80: 95-97.
19. Cuneo A, Bigoni R, Roberti MG, Bardi A, Balsamo R, Piva N, Castoldi GL. Detection of numerical aberrations in hematologic neoplasias by fluorescence in situ hybridization. Haematologica 1997; 82: 85-90.
20. Lion T. Debate round table. Monitoring of residual disease in chronic myelogenous leukemia: methodological approaches and clinical aspects. Leukemia 1996; 10: 896-900.
21. Hagemeijer A. Monitoring of residual disease in chronic myelogenous leukemia: methodological approaches and clinical aspects. Comments. Leukemia 1996; 10: 902-903.
22. Chase A, Grand F, Goldman J, Gordan M. Parameters affecting the interpretation of BCR-ABL fluorescence in situ hybridisation. Genes Chromosom Cancer 1997; 18: 246-253.
23. Muhlman J, Thaler J, Hilbe W, Bechter O, Erdel M, Uterman G, Duba HC. Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: a new strategy for remission assessment. Genes Chromosom Cancer 1998; 21: 90-100.
24. Haferlach T, Winkemann M, Nickenig C, Meeder M, Ramm-Petersen R, Schoch R, Nickelsen M, Weber-Matthiessen K, Schlegelberger B, Schoch C, Gassmann W, Loffler H. Which compartments are involved in Philadelphia-chromosome positive chronic myeloid leukaemia? An answer at the single cell level by combining May-Grunwald-Giemsa staining and fluorescence in situ hybridization techniques. Br J Haematol 1997; 97: 99-106.
25. Tefferi A, Schad CR, Pruthi RK, Ahmann GJ, Spurbeck JL, Dewald GW. Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia. Cancer Genet Cytogenet 1995; 83: 61-64.